United States · FDA National Drug Code directory
acamprosate calcium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-569_2e5f04a0-3e2d-494f-837b-18570b6a8546
- Product NDC
- 68382-569
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- acamprosate calcium
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170601
- Source listing expiry
- 20261231
Source-listed ingredients
- ACAMPROSATE CALCIUM — 333 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-01) · 68382-569-01
- 500 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-05) · 68382-569-05
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-06) · 68382-569-06
- 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-10) · 68382-569-10
- 90 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-16) · 68382-569-16
- 180 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-28) · 68382-569-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →